Is nonnephrotoxic immunosuppression a possibility?

Transplantation

Volumn 69, Issue 12 SUPPL., 2000, Pages

  Bäckman, Lars ^a   Morales, Jose M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CREATININE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN;

CONFERENCE PAPER; CREATININE BLOOD LEVEL; GRAFT SURVIVAL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOKALEMIA; IMMUNOSUPPRESSIVE TREATMENT; NEPHROTOXICITY; PRIORITY JOURNAL; PYELONEPHRITIS; TREMOR; VIRUS INFECTION;

EID: 0343090808     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200006271-00007     Document Type: Conference Paper

References (22)

1. Gummert JF, Ikonen T, Morris RE. Newer immunosuppressive drugs: a review. J Am Soc Nephrol 1999; 10: 1366-1380.
2. Sehgal SN. Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem 1998; 31(5): 335-340.
3. Stepkowski SM, Kahan BD. Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival. Transplant Proc 1991; 23(6): 3262-3264.
4. Andoh TF, Lindsley J, Franceschini N, Bennett WM. Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model. Transplantation 1996; 62(3): 311-316.
5. Häyry P. Chronic rejection: an update on the mechanism. Transplant Proc 1998; 30: 3993-3995.
6. Chávez R, Jamieson N, Takamori S, et al. Hepatotrophic effect of cyclosporine and FK 506 is not mimicked by rapamycin. Transplant Proc 1999; 31: 2429.
7. Watson CJE, Friend PJ, Jamieson NV, et al. Sirolimus: a potent new immunosuppressant for liver transplantation. Transplantation 1999; 67(4): 505-509.
8. Groth CG, Backman L, Morales J-M, et al. Sirolimus (rapamycin)-based therapy in human renal transplantation. Similar efficacy and different toxicity compared with cyclosporine. Transplantation 1999; 67(7): 1036-1042.
9. Kreis H, Durand D, Land W, et al. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation 2000; in press.
10. Pirsch JD, Miller J, Deierhoi MH, et al. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 1997; 63(7): 977-983.
11. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411-422.
12. Barbosa LM, Gauthier VJ, Davis CL. Bone pain that responds to calcium channel blockers. A retrospective and prospective study of transplant recipients. Transplantation 1995; 59(4): 541-544.
13. Stevens JM, Hilson JW, Sweny P. Post-renal transplant limb bone pain. An under-recognized complication of transplantation distinct from avascular necrosis of bone? Transplantation 1995; 60(3): 305-307.
14. Nankivell BJ, Gruenewald SM, Allen RD, Chapman JR. Predicting glomerular filtration rate after kidney transplantation. Transplantation 1995; 59(12): 1683-1689.
15. Perico N, Remuzzi G. Prevention of transplant rejection. Current treatment guidelines and future developments. Drugs 1997; 54(4): 533-570.
16. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996; 61(7): 1029-1037.
17. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection. Lancet 1995; 345(8961): 1321-1325.
18. Sollinger HW for the U.S. Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995; 60(3): 225-232.
19. Grinyó JM, Gil-Vernet S, Seron D, et al. Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft. Nephrol Dial Transplant 1998; 13(10): 2061-2064.
20. Vincenti F, Grinyo JM, Ramos E, et al. Can antibody prophylaxis allow sparing of other immunosuppressives? Transplant Proc 1999; 31: 1246-1248.
21. Oppenheimer F, Campistol JM, Garcia-Mena M, et al. Mycophenolate mofetil plus prednisone as induction therapy in suboptimal renal transplantation. Proceedings ESOT 1999; 116 (abstract).
22. Rigg KM. Renal transplantation: current status, complications and prevention. J Antimicrob Chemother 1995; 36(suppl B): 51-57.